We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Advancing Development of Coronavirus Vaccines and Therapeutics

App Note / Case Study  
Published: October 28, 2020
 
Advancing Development of Coronavirus Vaccines and Therapeutics content piece image

The outbreak of SARS-CoV-2 has resulted in a worldwide surge of research to develop vaccines and and COVID-19 treatments. Octet systems enable real-time, label-free analysis for determination of affinity, kinetics, and protein concentration. Use the microfluidic-free systems with 96- or 384-well microplates for purified or crude samples making it a significantly simpler and faster setup than other comparative technologies. This results in easy accessible data with high specificity and a decreased workload for the researcher.

Download this application note to discover:

  • The analytical techniques used to help develop vaccines and therapeutics for SARS-CoV-2
  • How these techniques can also be used to analyze viral biology to observe different strains of SARS virus
Related Topic Pages
The COVID-19 Pandemic
Infectious Diseases
Advertisement
Chosen for You
Dr. Clara Barker, posing in front of some laboratory equipment.
Article

Advocacy, Inclusion and Unconventional Routes into Science: A Q&A with Dr. Clara Barker
A picture of differentiated SH-SY5Y on Revivocell NANOSTACKS™.
Industry Insight

Redefining Preclinical Testing With High-Complexity In Vitro Models
A female scientist in a laboratory, conducting research with a Gas Chromatography-Mass Spectrometry (GC-MS) system.
Webinar

Hydrogen as a Carrier Gas for GC-MS

On-Demand
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter